Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Mutational load distribution analysis (MLDA) in pancreatic cancer

Mutational load distribution analysis (MLDA) in pancreatic cancer

82
Lynch, HenryCreighton University

No coordinating investigator defined.

No involved investigator sites defined.

Ki-ras
UNKNOWN
G.I. and Other Associated Cancers Research Group

Certain p16 mutation carriers showed mutation elevations in the specific Ki-ras and p53 alleles significantly higher than normal, similar to controls with pancreatitis. Two individuals from separate families started out with "low risk" readings subsequently converted to "high risk" categorization and remained there in each sequential exam.

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.